8
Oct
2024

Kaisha Lifesciences Pvt Ltd

Exhibitor at CPHI Milan 2024 stand 14D21, Finished Dosage Formulations
About Us

Kaisha Lifesciences is a young and innovative pharmaceutical company that strives to bring safe, high quality and highly effective medication to patients worldwide along with improving the ease and efficiency by which healthcare workers administer its products.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • IN
  • 2019
    On CPHI since
  • 25 - 49
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Primary activities
Contract Research Organisation
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 14D21, Finished Dosage Formulations

Products Featured at CPHI Milan 2024

  • Clindamycin Injection

    Product Clindamycin Injection

    Used to treat bacterial infections
  • Diclofenac Sodium Injection

    Product Diclofenac Sodium Injection

    Non-steroidal anti-inflammatory drug (NSAID) used for pain management
  • Enoxaparin Sodium Injection (Multidose)

    Product Enoxaparin Sodium Injection (Multidose)

     Available in multidose cartridges is an Anticoagulant (blood thinner) used to prevent blood clots that are sometimes called deep vein thrombosis (DVT), which can lead to blood clots in the lungs
  • Enoxaparin Sodium Injection Pre Filled Syringe

    Product Enoxaparin Sodium Injection Pre Filled Syringe

    Anticoagulant (blood thinner) used to prevent blood clots that are sometimes called deep vein thrombosis (DVT), which can lead to blood clots in the lungs
  • Esomeprazole for Injection

    Product Esomeprazole for Injection

    Esomeprazole is a proton pump inhibitor that decreases the amount of acid produced in the stomach.